Skip to main content
. 2015 Dec 2;5:17654. doi: 10.1038/srep17654

Table 6. Characteristics of patients with and without corticosteroids.

Variables No corticosteroids (n = 506) Corticosteroids use (n = 239) P
Gender (male, %) 251 (49.6) 114 (47.7) 0.684
Location (N, %)     <0.001
 Burn 8 (1.6) 1 (0.4)  
 Cardiac SICU 4 (0.8) 1 (0.4)  
 CCU 4 (0.8) 3 (1.3)  
 MICU 292 (57.7) 176 (73.6)  
 MICU/SICU 137 (27.1) 42 (17.6)  
 Neuro ICU 13 (2.6) 4 (1.7)  
 Others 3 (0.6) 5 (2.1)  
 SICU 29 (5.7) 4 (1.7)  
 Trauma 26 (3.2) 3 (1.3)  
Ethnic (N, %)     1
 Hispanic or Latino 58 (11.5) 28 (11.7)  
 Others 448 (88.5) 211 (88.3)  
Infection sites (N, %)     0.713
 Abdomen 49 (9.7) 16 (6.7)  
 Bacterial meningitis 2 (0.4) 2 (0.8)  
 Central line 1 (0.2) 1 (0.4)  
 Confirmed Swine Influenza A 1 (0.2) 0  
 Osteomyelitis 2 (0.4) 2 (0.8)  
 Others 41 (8.1) 13 (5.4)  
 Skin or soft tissue 18 (3.6) 11 (4.6)  
 Suspected infection 1 (0.2) 1 (0.4)  
 Thorax 356 (70.4) 177 (74.1)  
 Urinary tract 35 (6.9) 16 (6.7)  
Vasopressor (N, %) 259 (51.2) 149 (62.3) 0.005
APACHE III (median, IQR) 89 (70–109) 96.5 (79–117.2) <0.001
CVP (mmHg) 11 (8–14) 11 (9–15) 0.176
The number of quadrants with infiltrates (median, range) 4 (0–4) 4 (2–4) 0.037§
CK (mmol/l) 91 (40–233) 75 (31–195) 0.336
ALT (mmol/l) 26 (16–41) 27 (17–44) 0.298
CRP (mg/dl) 22.7 (13.5–31.35) 21.2 (10.98–30.60) 0.003
Urine output (24 hours) 1400 (785–2218) 1170 (645.2–1968) 0.063
PaO2 (mmHg) 84 (70–104.5) 83 (68–105) 0.700
Mortality (N,%) 127 (25.1) 78 (32.6) 0.039
Age (years) 55 (42–66) 56 (43–65) 0.866

Abbreviations: IQR: interquartile range; APACHE: acute physiology and chronic health evaluation; CVP: central venous pressure; CK: creatine kinase; CRP: C-reactive protein; PaO2: partial pressure of arterial oxygen.

§ statistical test was performed by using Cochran-Armitage trend test.